Michelle Glasgow, MD
Gynecologic Oncology · Canton, GANPI 1184882524
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,281 of the $4,503 with a category attached, or 72.9%. 29 manufacturers reported payments, led by Baxter Healthcare at 27.3% of the total. Reporting peaked in 2022 at $1,329 and has fallen 61.0% since, to $518 in 2025.
Across 148 payments — averaging $30.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$1K
- AstraZeneca$616
- Merck$455
- GSK$445
- Tesaro, Inc.$368
- Myriad Genetic Laboratories, Inc.$262
- plus $1K from 23 others
What the payments were for
- Consulting fees$1,21527%
- Food & beverage$3,28173%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 2 | $1,230 |
| AstraZeneca | 30 | $616 |
| Merck | 22 | $455 |
| GSK | 20 | $445 |
| Tesaro, Inc. | 18 | $368 |
| Myriad Genetic Laboratories, Inc. | 7 | $262 |
| Eisai Inc. | 8 | $171 |
| Pfizer | 7 | $142 |
| Amgen | 1 | $118 |
| Caris MPI, Inc. | 2 | $104 |
| Seagen Inc. | 3 | $87 |
| Clovis Oncology, Inc. | 5 | $68 |
| Coherus Oncology, Inc. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $54 |
| Johnson & Johnson | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 2 | $27 |
| Fortovia Therapeutics, Inc. | 2 | $26 |
| Biom'up France SAS | 1 | $26 |
| AbbVie | 1 | $25 |
| Immunogen, Inc. | 1 | $23 |
| Foundation Medicine, Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| Bayer | 1 | $20 |
| Solventum Corporation | 1 | $17 |
| Davol Inc. | 1 | $16 |
| Prescient Surgical | 1 | $16 |
| Coopersurgical, Inc. | 1 | $13 |
| Dysis Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,503 in reported general payments places this provider in the 60th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 32 | $437 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 18 | $237 |
| Oxycodone Hcl | 96 | $225 |
| Prochlorperazine Maleate | 27 | $174 |
| Gabapentin | 12 | $137 |
| Ibuprofen | 37 | $119 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Canton
- James BurkeSavannah$276K
- Benedict BenignoAtlanta$273K
- Sharad GhamandeAugusta$214K
- Ruchi GargNewnan$125K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Margarett EllisonMoultrie$81K
- Vijaya GalicGainesville$35K
- Guilherme CantuariaAtlanta$13K
- Mitzie-Ann DavisFayetteville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.